Cigall Kadoch - Jul 13, 2021 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Director, 10%+ Owner
Signature
/s /Allan Reine, M.D., Attorney-in-Fact
Stock symbol
FHTX
Transactions as of
Jul 13, 2021
Transactions value $
$0
Form type
4
Date filed
7/14/2021, 04:53 PM
Next filing
Dec 16, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FHTX Stock Option (right to buy) Award $0 +12.5K $0.00 12.5K Jul 13, 2021 Common Stock 12.5K $9.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options will vest in full on the first anniversary of the date of grant, subject to the director's continued service on our Board of Directors.